Abbott Labs (ABT) Holder Gamble Jones Investment Counsel Decreased Stake by $685,692 as Valuation Rose; Fiera Capital Stake In Tenaris S A (TS) Was Raised

Abbott Laboratories (NYSE:ABT) Logo

Fiera Capital Corp increased its stake in Tenaris S A (TS) by 5.15% based on its latest 2019Q2 regulatory filing with the SEC. Fiera Capital Corp bought 28,271 shares as the company’s stock declined 7.82% . The institutional investor held 577,174 shares of the steel and iron ore company at the end of 2019Q2, valued at $15.19M, up from 548,903 at the end of the previous reported quarter. Fiera Capital Corp who had been investing in Tenaris S A for a number of months, seems to be bullish on the $12.36B market cap company. The stock decreased 1.70% or $0.36 during the last trading session, reaching $20.82. About 805,659 shares traded. Tenaris S.A. (NYSE:TS) has declined 31.47% since October 1, 2018 and is downtrending. It has underperformed by 31.47% the S&P500. Some Historical TS News: 19/03/2018 - TENARIS TS.N : BARCLAYS RAISES TARGET PRICE TO $43 FROM $41; 16/03/2018 TENARIS TS.N : UBS RAISES TO NEUTRAL FROM SELL; 30/04/2018 - Fidelity Select Natural Resources Adds Tenaris; 26/04/2018 - Tenaris: Effect of U.S. Steel Tariffs Unclea; 26/04/2018 - Tenaris 1Q Net 40c/AD; 28/03/2018 - Tenaris Files Annual Report 2017 and Convenes Annual General Meeting of Shareholders and Extraordinary General Meeting of Shareholders; 28/03/2018 - Tenaris Files Annual Report 2017 and Convenes Annual General Meeting of Shareholders and Extraordinary General Meeting of Share; 26/04/2018 - TENARIS TENR.Ml - FULL EXTENT OF US SECTION 232 TARIFFS ON STEEL IMPORTS IS STILL UNCLEAR; 26/04/2018 - TENARIS- AS FAR AS IMPORTS OF STEEL PIPES ARE REDUCED BY QUOTAS OF 25% TARIFF, EXPECTS TO BE WELL PLACED TO INCREASE PRODUCTION AT US DOMESTIC FACILITIES; 21/05/2018 - TKC METALS CORP - QTRLY NET LOSS ATTRIBUTABLE 21.6 MLN PESOS VS LOSS OF 43.4 MLN PESOS

Gamble Jones Investment Counsel decreased its stake in Abbott Labs (ABT) by 3.07% based on its latest 2019Q2 regulatory filing with the SEC. Gamble Jones Investment Counsel sold 8,163 shares as the company’s stock rose 10.62% . The institutional investor held 257,440 shares of the major pharmaceuticals company at the end of 2019Q2, valued at $21.65M, down from 265,603 at the end of the previous reported quarter. Gamble Jones Investment Counsel who had been investing in Abbott Labs for a number of months, seems to be less bullish one the $146.41 billion market cap company. The stock decreased 0.99% or $0.83 during the last trading session, reaching $82.84. About 1.07M shares traded. Abbott Laboratories (NYSE:ABT) has risen 33.65% since October 1, 2018 and is uptrending. It has outperformed by 33.65% the S&P500. Some Historical ABT News: 11/04/2018 - ABBOTT BEGINS OCT STUDY IN CORONARY ARTERY DISEASE WITH STENT; 11/03/2018 - New Long-Term Data Show Improved Survival and Lower Rates of Stroke and Pump Thrombosis for Abbott’s HeartMate 3 Heart Pump; 20/04/2018 - Abbott Bond Trading 2x Average; Clients Net Sellers; 23/04/2018 - Sanquin Selects Abbott’s “Alinity™ s” Solution for Blood and Plasma Screening; 28/03/2018 - Abbott is taking its partnership with a diabetes care start-up one step further; 23/05/2018 - Abbott’s Investigational Tendyne™ Device for Mitral Valve Replacement Demonstrates Positive Outcomes at 30 Days in Global Study; 28/03/2018 - Abbott and Bigfoot previously agreed to integrate Abbott’s new continuous glucose monitor, FreeStyle Libre, with Bigfoot’s insulin delivery systems; 28/03/2018 - Abbott has invested an undisclosed amount in Bigfoot Biomedical, a start-up creating diabetes care devices and systems; 18/04/2018 - Abbott sticks to earlier forecasts, disappoints investors; 18/05/2018 - Texas Gov. Abbott Says 10 Dead, 10 Others Wounded in High School Shooting

Fiera Capital Corp, which manages about $26.41 billion US Long portfolio, decreased its stake in Franco Nevada Corp (NYSE:FNV) by 157,953 shares to 3.14 million shares, valued at $266.20M in 2019Q2, according to the filing. It also reduced its holding in Smith A O Corp (NYSE:AOS) by 47,837 shares in the quarter, leaving it with 693,798 shares, and cut its stake in Semtech Corp (NASDAQ:SMTC).

More notable recent Tenaris S.A. (NYSE:TS) news were published by: Globenewswire.com which released: “General Shareholders Meeting approves delisting of Tenaris’s shares from the Buenos Aires stock exchange - GlobeNewswire” on July 29, 2019, also Benzinga.com with their article: “9 Energy Stocks Moving In Tuesday’s Pre-Market Session - Benzinga” published on October 01, 2019, Globenewswire.com published: “Tenaris Convenes General Meeting of Shareholders NYSE:TS - GlobeNewswire” on June 26, 2019. More interesting news about Tenaris S.A. (NYSE:TS) were released by: Seekingalpha.com and their article: “AT&T’s ‘Underperformance’ Has Been No Great Tragedy - Seeking Alpha” published on September 13, 2019 as well as Benzinga.com‘s news article titled: “10 Energy Stocks Moving In Wednesday’s Pre-Market Session - Benzinga” with publication date: September 04, 2019.

Analysts await Abbott Laboratories (NYSE:ABT) to report earnings on October, 16. They expect $0.84 EPS, up 12.00% or $0.09 from last year’s $0.75 per share. ABT’s profit will be $1.48 billion for 24.65 P/E if the $0.84 EPS becomes a reality. After $0.82 actual EPS reported by Abbott Laboratories for the previous quarter, Wall Street now forecasts 2.44% EPS growth.

Investors sentiment increased to 0.89 in Q2 2019. Its up 0.07, from 0.82 in 2019Q1. It improved, as 46 investors sold ABT shares while 589 reduced holdings. 120 funds opened positions while 443 raised stakes. 1.26 billion shares or 0.12% less from 1.26 billion shares in 2019Q1 were reported. Coldstream Management Inc has 0.32% invested in Abbott Laboratories (NYSE:ABT). Tocqueville Asset LP invested in 395,012 shares or 0.43% of the stock. Old Dominion Cap Incorporated has invested 0.35% in Abbott Laboratories (NYSE:ABT). Livforsakringsbolaget Skandia Omsesidigt invested in 0.37% or 35,617 shares. Virginia-based Invest Management Of Virginia Ltd Liability Company has invested 1.91% in Abbott Laboratories (NYSE:ABT). Zurcher Kantonalbank (Zurich Cantonalbank) holds 0.49% or 690,093 shares. Bluestein R H And Communications invested 1.16% of its portfolio in Abbott Laboratories (NYSE:ABT). Becker Capital Management has 10,082 shares for 0.03% of their portfolio. Tekla Mgmt Limited Liability Com holds 1.73% or 504,148 shares in its portfolio. Wheatland Advsr holds 0.42% or 6,632 shares. Guardian Life Insurance Of America holds 0.06% of its portfolio in Abbott Laboratories (NYSE:ABT) for 5,088 shares. Atlas Browninc has invested 1.2% in Abbott Laboratories (NYSE:ABT). Farmers Commercial Bank owns 4,204 shares. Sandler Cap Mgmt reported 0.81% of its portfolio in Abbott Laboratories (NYSE:ABT). Callahan Advsr Lc stated it has 1.88% of its portfolio in Abbott Laboratories (NYSE:ABT).

Gamble Jones Investment Counsel, which manages about $1.24B and $1.17 billion US Long portfolio, upped its stake in Texas Instrs Inc (NASDAQ:TXN) by 7,766 shares to 226,850 shares, valued at $26.03 million in 2019Q2, according to the filing. It also increased its holding in Ishares Tr (SHY) by 4,291 shares in the quarter, for a total of 92,047 shares, and has risen its stake in Amgen Inc (NASDAQ:AMGN).

More notable recent Abbott Laboratories (NYSE:ABT) news were published by: Streetinsider.com which released: “Abbott (ABT) Announces FDA Approves its “Low Dose,” Recharge-Free Spinal Cord Stimulation System for People Living with Chronic Pain - StreetInsider.com” on September 26, 2019, also Finance.Yahoo.com with their article: “If You Had Bought Abbott Laboratories (NYSE:ABT) Stock Three Years Ago, You Could Pocket A 100% Gain Today - Yahoo Finance” published on September 19, 2019, Seekingalpha.com published: “Checking In On Our Dividend Growth Portfolios In 2019 - Seeking Alpha” on September 17, 2019. More interesting news about Abbott Laboratories (NYSE:ABT) were released by: Finance.Yahoo.com and their article: “Medtronic, Other Medtech Providers Could Face Additional Tariffs - Yahoo Finance” published on September 03, 2019 as well as Finance.Yahoo.com‘s news article titled: “At US$78.27, Is It Time To Put Abbott Laboratories (NYSE:ABT) On Your Watch List? - Yahoo Finance” with publication date: May 01, 2019.

Abbott Laboratories (NYSE:ABT) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.